Capital One Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$384K Sell
650
-338
-34% -$194K 0.27% 60
2021
Q4
$659K Buy
988
+1
+0.1% +$624 0.08% 108
2021
Q3
$564K Hold
987
0.07% 108
2021
Q2
$498K Sell
987
-200
-17% -$94.4K 0.06% 121
2021
Q1
$542K Sell
1,187
-200
-14% -$95.5K 0.07% 108
2020
Q4
$646K Sell
1,387
-5,744
-81% -$2.69M 0.09% 99
2020
Q3
$3.15M Sell
7,131
-15
-0.2% -$6.2K 0.4% 38
2020
Q2
$2.59M Hold
7,146
0.35% 49
2020
Q1
$2.03M Buy
+7,146
New +$2.25M 0.33% 62

Other funds holding TMO

Capital One Financial's TMO Position: Q1 2022 in Review

Capital One Financial reduced its Thermo Fisher Scientific (TMO) stake by 34% in Q1 2022, selling an estimated $194K and leaving 650 shares worth $384K. The position accounts for 0.27% of the portfolio, ranked #60.

Capital One Financial first reported a position in TMO in Q1 2020 and has held it in 9 quarters since. The position peaked at $3.15M in Q3 2020. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Capital One Financial held 650 shares of Thermo Fisher Scientific worth $384K as of Q1 2022.
  • Capital One Financial sold 338 Thermo Fisher Scientific shares in Q1 2022, an estimated $194K.
  • Thermo Fisher Scientific made up 0.27% of Capital One Financial's portfolio in Q1 2022, its #60 holding.
  • Capital One Financial first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 9 quarters since.
  • Capital One Financial's Thermo Fisher Scientific position peaked at $3.15M in Q3 2020.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Capital One Financial's 13F filing for Q1 2022, filed 13 Apr 2022.